Displaying 1 - 6 of 6
Altarum completed an economic case study of health information technology (IT) adoption in rural hospitals for Office of the National Coordinator for Health IT (ONC). This in-depth case study was designed to explore in detail the challenges and facilitators of successful health IT adoption in rural U.S. hospitals.
Altarum, in collaboration with Delta Dental, the University of Michigan (UM) School of Dentistry, and the Michigan Department of Community Health, is working on a comprehensive program to reduce the burden of childhood dental disease.
The Michigan Center for Effective Information Technology Adoption was established in 2010 to help physicians select, adopt, and implement EHRs.
The Regional Extension Center (REC) program was created to provide direct technical assistance to accelerate electronic health record (EHR) adoption. The RECs are a national learning network that provides on-the-ground assistance to help providers incorporate technology into care delivery.
National Institute of Neurological Disease and Stroke (NINDS) Center for Clinical Research Data Management, Methodology, Monitoring Services, Statistical Design, and Quality Control
KAI Research, Inc., a wholly owned for-profit subsidiary of Altarum, provided an array of clinical research support services for the National Institute of Neurological Disorders and Stroke (NINDS), which included monitoring quality assurance in Institute-sponsored clinical trials, development of a classification system of NINDS Research Projects; tracking clinical projects through the automated Clinical Information Project System (CLIPS); statistical and methodological support; data management services to the Specialized Program of Transitional Research in Acute Stroke (SPOTRIAS) network; and development of the NINDS Common Data Elements (CDE) data standards designed to facilitate data collection and data sharing.
Altarum studied the feasibility of designing a Web-based data system to use during a disaster to track and maintain the dispensing of medication to patients being treated for opioid dependence in the New York City metro area.